Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

ATHE

ATHE News

Newswire

07:32

Alterity Therapeutics to present at Bell Potter Healthcare Conference.

07:26

Alterity Therapeutics to Present at Bell Potter Healthcare Virtual Conference

07:36

Alterity Therapeutics showcases symptom stability and efficacy in MSA Phase 2 trial.

07:27

Alterity Therapeutics Presents Promising Results for ATH434 in MSA Treatment.

07:31

Alterity's ATH434 trials show efficacy and $2.4 bln peak sales potential in MSA.

View More

About ATHE

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More